Lundoch Diagnostics
Know your risk and stop diabetes!
Globally, almost 500 million people are affected by type 2 diabetes, and about 700 billion USD are spent per year on diabetes and care. It is a deadly disease, but it is now possible to know your risk and stop diabetes years before the condition strikes. Lundoch Diagnostics developed LDcoder®, the first and only technology in the world that detects diabetes risk in an individual at least 4 years before diagnosis, which helps you make the right choice to stop diabetes.
Lundoch: a company with a global mission
Lundoch Diagnostics was founded in 2020 at the campus of Lund University, Sweden. The foundation of the company is a scientific discovery led by Dr. Yang De Marinis (Assoc. Prof, Prof) in collaboration with 22 institutes, hospitals and universities from Sweden, Finland, Germany, US, UK, France, Switzerland, Italy, Denmark and China. This large international study discovered blood protein biomarkers that predict future type 2 diabetes many years before diagnosis.
Based on the scientific findings, Lundoch was founded and developed LDcoder®, which detects diabetes risk in an individual by AI-driven blood test at least 4 years before diagnosis. This innovative technology makes diabetes prevention possible through early risk screening and intervention in large populations globally.
Through our technology, Lundoch is marching a great mission: Save the world from Diabetes!
The technology: LDcoder®
LDcoder® is composed of an advanced AI machine-learning software together with patented blood biomarker analysis. It is performed on a tiny amount of blood sample, and can be easily implemented in any clinical labs.